Alzheimer's Disease: Cholinergic Therapy and Beyond
- 1 March 1998
- journal article
- review article
- Published by Elsevier in American Journal of Geriatric Psychiatry
- Vol. 6 (2) , S56-S63
- https://doi.org/10.1097/00019442-199821001-00008
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's DiseaseNew England Journal of Medicine, 1997
- Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's diseaseNeurology, 1996
- Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor proteinNature, 1995
- Inflammatory mechanisms in Alzheimer's disease: implications for therapyAmerican Journal of Psychiatry, 1994
- Physiological production of the β-amyloid protein and the mechanism of Alzheimer's diseaseTrends in Neurosciences, 1993
- Clinical trial of indomethacin in Alzheimer's diseaseNeurology, 1993
- A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's DiseaseNew England Journal of Medicine, 1992
- β-Amyloid and the Pathogenesis of Alzheimer's DiseaseNew England Journal of Medicine, 1991
- Neurotransmitter-related enzymes in senile dementia of the alzheimer typeBrain Research, 1979
- Human Memory and the Cholinergic SystemArchives of Neurology, 1974